Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126089611 | 12608961 | 1 | I | 20150126 | 20160731 | 20160731 | EXP | IN-ALEMBIC PHARMACUETICALS LIMITED-2015SCAL000925 | ALEMBIC | RIZVI I, ET AL.. ISOLATED EXTRA PONTINE MYELINOLYSIS PRESENTING AS ACUTE ONSET PARKINSONISM. BMJ CASE REPORTS 2012. 2012 | 0.00 | Y | 0.00000 | 20160731 | OT | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126089611 | 12608961 | 1 | PS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 12.5 MG, UNK | 200645 | 12.5 | MG | |||||||||
| 126089611 | 12608961 | 2 | SS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126089611 | 12608961 | 1 | Hypertension |
| 126089611 | 12608961 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126089611 | 12608961 | HO |
| 126089611 | 12608961 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126089611 | 12608961 | Encephalopathy | |
| 126089611 | 12608961 | Hyponatraemia | |
| 126089611 | 12608961 | Osmotic demyelination syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |